As China embraces AI, only 24% of US pharma execs bet on it for drug-making
Pharmaceutical companies have embraced artificial intelligence in drug research almost universally, yet few company executives expect AI to actually make drugs succeed, according to a Citi survey released on Tuesday. “The biggest risk to the AI-powered drug discovery thesis is not that AI fails to...
Why this byte is shareable
Signal quality
observed
Confidence badge and source context included.
Entity anchor
AI News
Clear company or model context for distribution.
Export ready
1200 x 630 card
Optimized for X, LinkedIn, and chat previews.
Why it matters
AI News is moving the AI stack right now, and this update helps explain what changed for builders.
Suggested launch post
Use this in X threads, community posts, internal team chats, or launch recaps.
As China embraces AI, only 24% of US pharma execs bet on it for drug-making Why it matters: AI News is moving the AI stack right now, and this update helps explain what changed for builders. Source: Biztoc https://a2zai.ai/bytes/as-china-embraces-ai-only-24-of-us-pharma-exec...
Permalink: https://a2zai.ai/bytes/as-china-embraces-ai-only-24-of-us-pharma-execs-bet-on-it-for-drug-making-8dc11f58
Social card: https://a2zai.ai/bytes/as-china-embraces-ai-only-24-of-us-pharma-execs-bet-on-it-for-drug-making-8dc11f58/opengraph-image